Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zoetis (NY:ZTS)

71.86 -1.39 (-1.90%)
Official Closing Price Updated: 7:00 PM EDT, Jun 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zoetis

< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
News headline image
Pet Products Sector Shows Robust Resilience Amidst Cross-Border Strategic Alignment on November 7, 2025
As of November 7, 2025, the Pet Products Sector continues to demonstrate remarkable resilience and growth within the S&P 500, buoyed by enduring consumer trends and strategic market alignments.... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
3 Dividend Stocks Down 11%, 29%, and 41% to Buy in November ↗
These stocks aren't popular right now, but their strong underlying businesses make them hot deals to pounce on. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Earnings Season Echoes: Navigating the Volatility of Corporate Reports
The financial markets are once again in the throes of earnings season, a period that consistently proves to be a crucible for individual stock valuations and a significant driver of broader market... 
Via MarketMinute
Topics Artificial Intelligence Economy Supply Chain
News headline image
Earnings Scheduled For November 4, 2025 ↗
 
Via Benzinga
News headline image
Curious about which S&P500 stocks are generating unusual volume on Wednesday? Find out below. ↗
Curious about which S&P500 stocks are generating unusual volume on Wednesday? Find out below. 
Via Chartmill
News headline image
Exploring the top movers within the S&P500 index during today's session. ↗
Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
News headline image
ZTS Q3 Deep Dive: Flat Sales, Guidance Cut Amid Competitive and Market Pressures
Animal health company Zoetis (NYSE:ZTS) met Wall Streets revenue expectations in Q3 CY2025, but sales were flat year on year at $2.4 billion. On the other hand, the company’s full-year revenue guidance... 
Via StockStory
News headline image
Why Zoetis (ZTS) Shares Are Plunging Today
Shares of animal health company Zoetis (NYSE:ZTS) fell 12.6% in the morning session after the company reported mixed third-quarter results and cut its full-year sales forecast. Although its adjusted... 
Via StockStory
Topics Earnings
News headline image
Which S&P500 stocks are moving on Tuesday? ↗
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Tuesday as we examine the latest happenings in today's session. 
Via Chartmill
News headline image
Zoetis Stock Outlook Clouded By Rising Competitive Pressures ↗
Zoetis tops Q3 earnings estimates but trims 2025 sales forecast as companion animal growth slows and competition weighs on its outlook. 
Via Benzinga
News headline image
Tuesday's session: top gainers and losers in the S&P500 index ↗
Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill
News headline image
Which S&P500 stocks are gapping on Tuesday? ↗
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Tuesday. Stay informed about the latest market trends. 
Via Chartmill
News headline image
Zoetis Inc (NYSE:ZTS) Stock Plummets Over 11% on Q3 Revenue Miss and Lowered 2025 Guidance ↗
Zoetis (ZTS) Q3 2025 results show an EPS beat but a revenue miss and lowered full-year sales guidance, causing a sharp pre-market stock drop. 
Via Chartmill
News headline image
Get insights into the top movers in the S&P500 index of Tuesday's pre-market session. ↗
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements. 
Via Chartmill
News headline image
Zoetis Stock Crumbles After Slashing 2025 Sales Outlook ↗
The animal health company now expects $9.4 billion-$9.475 billion in sales for the year. 
Via Investor's Business Daily
News headline image
Zoetis (NYSE:ZTS) Reports Q3 In Line With Expectations But Stock Drops
Animal health company Zoetis (NYSE:ZTS) met Wall Streets revenue expectations in Q3 CY2025, but sales were flat year on year at $2.4 billion. On the other hand, the company’s full-year revenue guidance... 
Via StockStory
News headline image
Zoetis Announces Third Quarter 2025 Results
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis Announces Retirement of Rob Polzer at the End of 2025 and the Appointment of Kevin Esch as President of Research & Development for World Leader in Animal Health Beginning in 2026
From Zoetis Inc.
Via Business Wire
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
How Idexx Laboratories Business Shook Off Bears And Hit A Record ↗
Idexx Laboratories catapulted to a record high Monday after the vet diagnostics outlet beat quarterly forecasts. 
Via Investor's Business Daily
News headline image
What To Expect From Zoetis’s (ZTS) Q3 Earnings
Animal health company Zoetis (NYSE:ZTS) will be reporting results this Tuesday morning. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence
News headline image
2 Magnificent Dividend Stocks to Buy and Hold Forever ↗
Some might call them boring businesses, but they have tremendous dividend growth track records. 
Via The Motley Fool
Topics Economy Intellectual Property
News headline image
1 Safe-and-Steady Stock with Competitive Advantages and 2 We Turn Down
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
News headline image
Zoetis Receives European Commission Marketing Authorization for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis Appoints Stephanie Tilenius to its Board of Directors
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis Stock: Outlook Remains Muted ↗
Adhishthana.com analysis reveals why Zoetis stock may remain sluggish through June 2026, as weak triads weigh on its final phase. 
Via Benzinga
News headline image
2 Large-Cap Stocks with Exciting Potential and 1 We Avoid
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an... 
Via StockStory
News headline image
Zoetis Announces Health Canada Approval of Lenivia® (izenivetmab injection) for Alleviation of Osteoarthritis (OA) Pain in Dogs
From Zoetis Inc.
Via Business Wire
News headline image
1 Profitable Stock for Long-Term Investors and 2 Facing Headwinds
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential. 
Via StockStory
News headline image
Zoetis Receives Positive Opinion from CVMP for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs
From Zoetis Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.